Neoadjuvant androgen deprivation for prostate volume reduction: the optimal duration in prostate cancer radiotherapy. [electronic resource]
Producer: 20110505Description: 52-7 p. digitalISSN:- 1873-2496
- Aged
- Androgen Antagonists -- therapeutic use
- Buserelin -- therapeutic use
- Chemotherapy, Adjuvant
- Cohort Studies
- Drug Therapy, Combination
- Fertility Agents, Female -- therapeutic use
- Humans
- Imidazolidines -- therapeutic use
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Prostatic Neoplasms -- drug therapy
- Survival Rate
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.